Literature DB >> 26274747

The role of WNT signalling in urothelial cell carcinoma.

I Ahmad1.   

Abstract

Urothelial cell carcinoma (UCC) of the bladder is one of the most common malignancies, causing considerable morbidity and mortality worldwide. It is unique among the epithelial carcinomas as two distinct pathways to tumourigenesis appear to exist: low grade, recurring papillary tumours usually contain oncogenic mutations in FGFR3 or HRAS whereas high grade, muscle invasive tumours with metastatic potential generally have defects in the pathways controlled by the tumour suppressors p53 and retinoblastoma. Over the last two decades, a number of transgenic mouse models of UCC, containing deletions or mutations of key tumour suppressor genes or oncogenes, have helped us understand the mechanisms behind tumour development. In this summary, I present my work investigating the role of the WNT signalling cascade in UCC.

Entities:  

Keywords:  Bladder cancer; Mouse models; Transgenics; Urothelial cell carcinoma; WNT

Mesh:

Substances:

Year:  2015        PMID: 26274747      PMCID: PMC5210134          DOI: 10.1308/rcsann.2015.0008

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  54 in total

1.  Prognostic value of the expression of E-cadherin and beta-catenin in bladder cancer.

Authors:  X Garcia del Muro; A Torregrosa; J Muñoz; X Castellsagué; E Condom; F Vigués; A Arance; A Fabra; J R Germà
Journal:  Eur J Cancer       Date:  2000-02       Impact factor: 9.162

2.  Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse.

Authors:  Lara S Collier; Corey M Carlson; Shruthi Ravimohan; Adam J Dupuy; David A Largaespada
Journal:  Nature       Date:  2005-07-14       Impact factor: 49.962

3.  Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma.

Authors:  Francisco Ayala de la Peña; Keizo Kanasaki; Megumi Kanasaki; Neelima Tangirala; Genta Maeda; Raghu Kalluri
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

4.  Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer.

Authors:  Carmen J Marsit; Margaret R Karagas; Angeline Andrew; Mei Liu; Hadi Danaee; Alan R Schned; Heather H Nelson; Karl T Kelsey
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

5.  Intravesical delivery of rapamycin suppresses tumorigenesis in a mouse model of progressive bladder cancer.

Authors:  Catherine M Seager; Anna M Puzio-Kuter; Trushar Patel; Shalini Jain; Carlos Cordon-Cardo; James Mc Kiernan; Cory Abate-Shen
Journal:  Cancer Prev Res (Phila)       Date:  2009-12-01

Review 6.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

7.  Inactivation of p53 and Pten promotes invasive bladder cancer.

Authors:  Anna M Puzio-Kuter; Mireia Castillo-Martin; Carolyn W Kinkade; Xi Wang; Tian Huai Shen; Tulio Matos; Michael M Shen; Carlos Cordon-Cardo; Cory Abate-Shen
Journal:  Genes Dev       Date:  2009-03-04       Impact factor: 11.361

Review 8.  Metastatic bladder cancer. Natural history, clinical course, and consideration for treatment.

Authors:  G D Steinberg; D L Trump; K B Cummings
Journal:  Urol Clin North Am       Date:  1992-11       Impact factor: 2.241

9.  Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer.

Authors:  H Miyamoto; T Shuin; I Ikeda; M Hosaka; Y Kubota
Journal:  J Urol       Date:  1996-04       Impact factor: 7.450

10.  Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesis.

Authors:  I Ahmad; R Patel; Y Liu; L B Singh; M M Taketo; X-R Wu; H Y Leung; O J Sansom
Journal:  Cell Death Dis       Date:  2011-03-03       Impact factor: 8.469

View more
  1 in total

1.  Wnt/β-Catenin Signalling and Its Cofactor BCL9L Have an Oncogenic Effect in Bladder Cancer Cells.

Authors:  Roland Kotolloshi; Mieczyslaw Gajda; Marc-Oliver Grimm; Daniel Steinbach
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.